Poverty and Childhood Cancer Outcomes: A Novel Intervention Target

One in six children diagnosed with cancer in the United States lives in poverty, and despite uniform treatment in clinical trials, poverty-exposed children are more likely to relapse compared to children who are not exposed to poverty. Dana-Farber Cancer Institute seeks to improve childhood cancer outcomes by investigating poverty as a risk factor for relapse and developing novel poverty-targeted interventions. Listen to a presentation from Dana-Farber’s Kira Bona, MD, MPH, about her lab’s work to identify and alleviate poverty-associated outcome disparities in childhood cancers. The event is hosted by Joanne Wolfe, MD, MPH.